Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENTEX CORP Director's Dealing 2025

Feb 21, 2025

30893_dirs_2025-02-21_f98c7d70-d1d0-4aff-b2bb-486bac90dd8a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2025-02-20

Reporting Person: Ryan Scott P (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-20 Common Stock A 8370.00 $0.00 Acquired 40852.00 Direct

Footnotes

F1: These shares vest 100% three years from grant award date.